The prevalence of chronic obstructive pulmonary disease in Elazig, Eastern Turkey

dc.contributor.authorDeveci, Figen
dc.contributor.authorDeveci, S. Erhan
dc.contributor.authorTurkoglu, Suat
dc.contributor.authorTurgut, Teyfik
dc.contributor.authorKirkil, Gamze
dc.contributor.authorRahman, Suheyla
dc.contributor.authorMuz, M. Hamdi
dc.date.accessioned2026-08-12T17:46:13Z
dc.date.issued2011
dc.departmentFırat Üniversitesi
dc.description.abstractBackground: To investigate the prevalence of Chronic Obstructive Pulmonary Disease (COPD) in the urban and rural areas of the Elazig Region of Turkey. Methods: A questionnaire was conducted and spirometric measurements were made, based on the BOLD protocol. A total of 1270 individuals, over 18 years of age, were included in the study, comprising 610 individuals from the city center and 660 from the rural area. The questionnaire included demographics, symptoms and possible risk factors. The description and staging of COPD were in accordance with GOLD (Global Initiative for Chronic Obstructive Lung Disease). Results: Of the 1270 cases, 1206 (94.9%) were able to complete the questionnaire and undergo spirometric analysis. Of these 1206 cases, 1188 (98.5%) were used in the final assessment; the remainder were excluded due to errors in the spirometric analysis. Of the cases included in the study, 43.2% (25.9% female; 56.7% male) were current smokers. The prevalence of COPD at >= 18 years old was 4.5% (female 2.5%; male 6%); the prevalence at >= 45 years old was 11.5% (female 5.9%; male 15.1%). The majority of the COPD cases were at stages I and II (22.6% and 66%, respectively). The prevalence of COPD was higher among current and former smokers (5.8%) than non-smokers (2.8%). In general, the risk factors for COPD were found to be age, male gender, smoking, living in a rural area, and low income. Conclusions: The prevalence of COPD in Elazig, Turkey was highest among the elderly and smokers, and constituted primarily stages I and II of the disease. (C) 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
dc.identifier.doi10.1016/j.ejim.2010.12.014
dc.identifier.endpage176
dc.identifier.issn0953-6205
dc.identifier.issn1879-0828
dc.identifier.issue2
dc.identifier.pmid21402248
dc.identifier.scopus2-s2.0-79952702542
dc.identifier.scopusqualityQ1
dc.identifier.startpage172
dc.identifier.urihttps://doi.org/10.1016/j.ejim.2010.12.014
dc.identifier.urihttps://hdl.handle.net/11508/61000
dc.identifier.volume22
dc.identifier.wosWOS:000288240100010
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofEuropean Journal of Internal Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectChronic obstructive pulmonary disease
dc.subjectPrevalence
dc.subjectRisk factors
dc.titleThe prevalence of chronic obstructive pulmonary disease in Elazig, Eastern Turkey
dc.typeArticle

Dosyalar